Tag: Joint Action 3

ISPOR COMMENTS ON PROPOSED EUROPEAN UNION COOPERATION ON HEALTH TECHNOLOGY ASSESSMENT

Society’s Comments Emphasize Need for Ongoing Collaboration and Observation of HTA Good Practices   Princeton, NJ—January 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has submitted comments in response to the European Commission’s request for public consultation regarding

Posted in Announcements, ISPOR News & Press Tagged with: , , ,